{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:17:48Z","timestamp":1792721868677,"version":"4.5.0"},"reference-count":100,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T00:00:00Z","timestamp":1700006400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002397","name":"Shanghai University of Sport","doi-asserted-by":"publisher","award":["2022KF001"],"award-info":[{"award-number":["2022KF001"]}],"id":[{"id":"10.13039\/501100002397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003395","name":"Shanghai Municipal Education Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003395","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002338","name":"Ministry of Education of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003024","name":"Shanghai Education Development Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ginseng Research"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jgr.2023.11.004","type":"journal-article","created":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T19:21:57Z","timestamp":1700076117000},"page":"129-139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["The pharmacological role of Ginsenoside Rg3 in liver diseases: A review on molecular mechanisms"],"prefix":"10.1016","volume":"48","author":[{"given":"Wenhong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihua","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jgr.2023.11.004_bib1","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jhep.2019.03.004","article-title":"Global liver disease burdens and research trends: analysis from a Chinese perspective","volume":"71","author":"Xiao","year":"2019","journal-title":"J Hepatol"},{"issue":"8","key":"10.1016\/j.jgr.2023.11.004_bib2","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"issue":"13","key":"10.1016\/j.jgr.2023.11.004_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22136777","article-title":"Liver disease: induction, progression, immunological mechanisms, and therapeutic interventions","volume":"22","author":"Neshat","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jgr.2023.11.004_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111927","article-title":"Molecular mechanisms and therapeutic implications of dihydromyricetin in liver disease","volume":"142","author":"Chen","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jgr.2023.11.004_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174604","article-title":"Preventive and therapeutic role of betaine in liver disease: a review on molecular mechanisms","volume":"912","author":"Wang","year":"2021","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jgr.2023.11.004_bib6","article-title":"Old wine in new bottles: kaempferol is a promising agent for treating the trilogy of liver diseases","volume":"175","author":"Xiao","year":"2021","journal-title":"Pharmacol Res"},{"issue":"2","key":"10.1016\/j.jgr.2023.11.004_bib7","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00204-007-0224-3","article-title":"Protective effects of ginsenoside Rg(3) against cyclophosphamide-induced DNA damage and cell apoptosis in mice","volume":"82","author":"Zhang","year":"2008","journal-title":"Arch Toxicol"},{"issue":"3","key":"10.1016\/j.jgr.2023.11.004_bib8","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2174\/157016109788340767","article-title":"Ginseng compounds: an update on their molecular mechanisms and medical applications","volume":"7","author":"L\u00fc","year":"2009","journal-title":"Current Vascular Pharmacol"},{"issue":"3","key":"10.1016\/j.jgr.2023.11.004_bib9","first-page":"259","article-title":"Cancer prevention and therapeutics: Panax ginseng, Alternative medicine review","volume":"9","author":"Helms","year":"2004","journal-title":"J Clinical Therapeut"},{"issue":"1","key":"10.1016\/j.jgr.2023.11.004_bib10","doi-asserted-by":"crossref","first-page":"124","DOI":"10.5142\/jgr.2013.37.124","article-title":"Characterizing a full spectrum of physico-chemical properties of (20S)- and (20R)-ginsenoside Rg3 to be proposed as standard reference materials","volume":"37","author":"Kim","year":"2013","journal-title":"J Ginseng Res"},{"issue":"6","key":"10.1016\/j.jgr.2023.11.004_bib11","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jgr.2021.03.002","article-title":"Ginsenoside Rg3 ameliorates allergic airway inflammation and oxidative stress in mice","volume":"45","author":"Huang","year":"2021","journal-title":"J Ginseng Res"},{"issue":"12","key":"10.1016\/j.jgr.2023.11.004_bib12","article-title":"Ginsenoside Rg3 attenuates TNF-\u03b1-induced damage in chondrocytes through regulating SIRT1-mediated anti-apoptotic and anti-inflammatory mechanisms","volume":"10","author":"Ma","year":"2021","journal-title":"Antioxidants (Basel)"},{"issue":"3","key":"10.1016\/j.jgr.2023.11.004_bib13","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1007\/s11033-021-06187-2","article-title":"Insights into the antitumor mechanism of ginsenosides Rg3","volume":"48","author":"Liu","year":"2021","journal-title":"Mol Biol Rep"},{"issue":"3","key":"10.1016\/j.jgr.2023.11.004_bib14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.14740\/gr1405","article-title":"A focused review on recent advances in the diagnosis and treatment of viral hepatitis","volume":"14","author":"Zhang","year":"2021","journal-title":"Gastroenterol Res"},{"issue":"26","key":"10.1016\/j.jgr.2023.11.004_bib15","doi-asserted-by":"crossref","first-page":"4018","DOI":"10.3748\/wjg.v27.i26.4018","article-title":"Viral hepatitis update: progress and perspectives","volume":"27","author":"Pisano","year":"2021","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10.1016\/j.jgr.2023.11.004_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/cells9061486","article-title":"Hepatitis B virus entry into cells","volume":"9","author":"Herrscher","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jgr.2023.11.004_bib17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/978-3-030-57362-1_3","article-title":"Mechanisms of hepatitis B virus-induced hepatocarcinogenesis","author":"Lee","year":"2021","journal-title":"Viruses and Human Cancer"},{"key":"10.1016\/j.jgr.2023.11.004_bib18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/978-981-10-5765-6_2","article-title":"Hepatitis B virus-associated hepatocellular carcinoma","volume":"1018","author":"Xie","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jgr.2023.11.004_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.691766","article-title":"The functions of hepatitis B virus encoding proteins: viral persistence and liver pathogenesis","volume":"12","author":"Zhao","year":"2021","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.jgr.2023.11.004_bib20","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1016\/j.biocel.2013.08.016","article-title":"Stimulation of TRAF6\/TAK1 degradation and inhibition of JNK\/AP-1 signalling by ginsenoside Rg3 attenuates hepatitis B virus replication","volume":"45","author":"Kang","year":"2013","journal-title":"Int J Biochem Cell Biol"},{"issue":"3","key":"10.1016\/j.jgr.2023.11.004_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2021.101626","article-title":"HCV virology and diagnosis","volume":"45","author":"Roger","year":"2021","journal-title":"Clinics Res Hepatol Gastroenterol"},{"issue":"5","key":"10.1016\/j.jgr.2023.11.004_bib22","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jiph.2019.11.015","article-title":"Overview of hepatitis C infection, molecular biology, and new treatment","volume":"13","author":"Rabaan","year":"2020","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.jgr.2023.11.004_bib23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.freeradbiomed.2018.09.044","article-title":"Mitochondrial damage and iron metabolic dysregulation in hepatitis C virus infection","volume":"133","author":"Hino","year":"2019","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"10.1016\/j.jgr.2023.11.004_bib24","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/hep.29177","article-title":"Ginsenoside Rg3 restores hepatitis C virus-induced aberrant mitochondrial dynamics and inhibits virus propagation","volume":"66","author":"Kim","year":"2017","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jgr.2023.11.004_bib25","doi-asserted-by":"crossref","first-page":"80","DOI":"10.5142\/jgr.2013.37.80","article-title":"Protective effect of ginsenoside-Rb2 from Korean red ginseng on the lethal infection of haemagglutinating virus of Japan in mice","volume":"37","author":"Yoo","year":"2013","journal-title":"J Ginseng Res"},{"issue":"Suppl 6","key":"10.1016\/j.jgr.2023.11.004_bib26","doi-asserted-by":"crossref","first-page":"s104","DOI":"10.7861\/clinmedicine.16-6-s104","article-title":"Drug-induced liver injury","volume":"16","author":"Katarey","year":"2016","journal-title":"Clinical Medicine (London, England)"},{"issue":"2","key":"10.1016\/j.jgr.2023.11.004_bib27","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.cld.2012.03.002","article-title":"Drug-induced liver disease","volume":"16","author":"Davern","year":"2012","journal-title":"Clin Liver Dis"},{"issue":"7","key":"10.1016\/j.jgr.2023.11.004_bib28","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/liv.12046","article-title":"Korean red ginseng extract prevents APAP-induced hepatotoxicity through metabolic enzyme regulation: the role of ginsenoside Rg3, a protopanaxadiol","volume":"33","author":"Gum","year":"2013","journal-title":"Liver Int"},{"key":"10.1016\/j.jgr.2023.11.004_bib29","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/957947","article-title":"The amelioration of N-acetyl-p-benzoquinone imine toxicity by ginsenoside Rg3: the role of Nrf2-mediated detoxification and Mrp1\/Mrp3 transports","volume":"2013","author":"Gum","year":"2013","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.jgr.2023.11.004_bib30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.intimp.2018.03.030","article-title":"20(R)-ginsenoside Rg3, a rare saponin from red ginseng, ameliorates acetaminophen-induced hepatotoxicity by suppressing PI3K\/AKT pathway-mediated inflammation and apoptosis","volume":"59","author":"Zhou","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jgr.2023.11.004_bib31","article-title":"Mechanism of mitophagy and its role in sepsis induced organ dysfunction: a review","volume":"9","author":"Zhu","year":"2021","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"10.1016\/j.jgr.2023.11.004_bib32","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nrgastro.2016.168","article-title":"Liver - guardian, modifier and target of sepsis","volume":"14","author":"Strnad","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jgr.2023.11.004_bib33","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.3389\/fphys.2019.01071","article-title":"The role of autophagy in sepsis: protection and injury to organs","volume":"10","author":"Yin","year":"2019","journal-title":"Front Physiol"},{"issue":"4","key":"10.1016\/j.jgr.2023.11.004_bib34","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20170934","article-title":"Ginsenoside Rg3 attenuates sepsis-induced injury and mitochondrial dysfunction in liver via AMPK-mediated autophagy flux","volume":"37","author":"Xing","year":"2017","journal-title":"Biosci Rep"},{"issue":"1","key":"10.1016\/j.jgr.2023.11.004_bib35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12950-021-00296-2","article-title":"Ginsenoside Rg3 alleviates septic liver injury by regulating the lncRNA TUG1\/miR-200c-3p\/SIRT1 axis","volume":"18","author":"Wu","year":"2021","journal-title":"J Inflamm (Lond)"},{"key":"10.1016\/j.jgr.2023.11.004_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2021.111372","article-title":"D-galactose-induced liver aging model: its underlying mechanisms and potential therapeutic interventions","volume":"150","author":"Azman","year":"2021","journal-title":"Exp Gerontol"},{"issue":"5","key":"10.1016\/j.jgr.2023.11.004_bib37","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1142\/S0192415X20500561","article-title":"Rare ginsenoside 20(R)-Rg3 inhibits D-galactose-induced liver and kidney injury by regulating oxidative stress-induced apoptosis","volume":"48","author":"Li","year":"2020","journal-title":"Am J Chin Med"},{"key":"10.1016\/j.jgr.2023.11.004_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115323","article-title":"Cisplatin in cancer treatment","volume":"206","author":"Romani","year":"2022","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jgr.2023.11.004_bib39","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.critrevonc.2019.03.004","article-title":"Role of epigenetic mechanisms in cisplatin-induced toxicity","volume":"137","author":"Quintanilha","year":"2019","journal-title":"Critical Rev Oncol\/hematol"},{"issue":"7","key":"10.1016\/j.jgr.2023.11.004_bib40","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1016\/j.fct.2012.01.005","volume":"50","author":"Lee","year":"2012","journal-title":"Food Chem Toxicol"},{"issue":"3","key":"10.1016\/j.jgr.2023.11.004_bib41","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.jep.2012.03.038","article-title":"Korean red ginseng and its primary ginsenosides inhibit ethanol-induced oxidative injury by suppression of the MAPK pathway in TIB-73 cells","volume":"141","author":"Park","year":"2012","journal-title":"J Ethnopharmacol"},{"issue":"10","key":"10.1016\/j.jgr.2023.11.004_bib42","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1248\/bpb.28.1992","article-title":"Hepatoprotective effect of 20(S)-ginsenosides Rg3 and its metabolite 20(S)-ginsenoside Rh2 on tert-butyl hydroperoxide-induced liver injury","volume":"28","author":"Lee","year":"2005","journal-title":"Biol Pharm Bull"},{"issue":"10","key":"10.1016\/j.jgr.2023.11.004_bib43","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1080\/10715760701581740","article-title":"Preventive effect of 20(S)-ginsenoside Rg3 against lipopolysaccharide-induced hepatic and renal injury in rats","volume":"41","author":"Kang","year":"2007","journal-title":"Free Radic Res"},{"issue":"7","key":"10.1016\/j.jgr.2023.11.004_bib44","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nature Medicine"},{"issue":"12","key":"10.1016\/j.jgr.2023.11.004_bib45","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/s41575-021-00502-9","article-title":"Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests","volume":"18","author":"Masoodi","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.jgr.2023.11.004_bib46","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","article-title":"Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016\u20132030","volume":"69","author":"Estes","year":"2018","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.jgr.2023.11.004_bib47","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jhep.2021.09.007","article-title":"NAFLD-driven HCC: safety and efficacy of current and emerging treatment options","volume":"76","author":"Foerster","year":"2022","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.jgr.2023.11.004_bib48","doi-asserted-by":"crossref","first-page":"5729","DOI":"10.3390\/ijms13055729","article-title":"Ginsenoside Rg3 reduces lipid accumulation with AMP-Activated Protein Kinase (AMPK) activation in HepG2 cells","volume":"13","author":"Lee","year":"2012","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.jgr.2023.11.004_bib49","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1530\/JOE-17-0233","article-title":"Ginsenoside Rg3 ameliorated HFD-induced hepatic steatosis through downregulation of STAT5-PPARgamma","volume":"235","author":"Lee","year":"2017","journal-title":"J Endocrinol"},{"issue":"11","key":"10.1016\/j.jgr.2023.11.004_bib50","doi-asserted-by":"crossref","first-page":"6020","DOI":"10.1039\/C8FO01056K","article-title":"Protective effects of enhanced minor ginsenosides in Lactobacillus fermentum KP-3-fermented ginseng in mice fed a high fat diet","volume":"9","author":"Nan","year":"2018","journal-title":"Food Funct"},{"issue":"5","key":"10.1016\/j.jgr.2023.11.004_bib51","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1007\/s10620-016-4049-x","article-title":"Innate immunity and inflammation in NAFLD\/NASH","volume":"61","author":"Arrese","year":"2016","journal-title":"Dig Dis Sci"},{"issue":"7503","key":"10.1016\/j.jgr.2023.11.004_bib52","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nature13475","article-title":"Sphingolipid metabolites in inflammatory disease","volume":"510","author":"Maceyka","year":"2014","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.jgr.2023.11.004_bib53","doi-asserted-by":"crossref","first-page":"222","DOI":"10.2174\/1389201020666190311143554","article-title":"Combined amelioration of ginsenoside (Rg1, Rb1, and Rg3)-enriched Korean red ginseng and probiotic lactobacillus on non-alcoholic fatty liver disease","volume":"20","author":"Kim","year":"2019","journal-title":"Current Pharmaceut Biotechnol"},{"issue":"12","key":"10.1016\/j.jgr.2023.11.004_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/nu11122963","article-title":"Fermented Korean red ginseng extract enriched in rd and Rg3 protects against non-alcoholic fatty liver disease through regulation of mTORC1","volume":"11","author":"Choi","year":"2019","journal-title":"Nutrients"},{"issue":"10","key":"10.1016\/j.jgr.2023.11.004_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/biom10101426","article-title":"Pharmaceutical efficacy of gypenoside LXXV on non-alcoholic steatohepatitis (NASH)","volume":"10","author":"Lee","year":"2020","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.jgr.2023.11.004_bib56","doi-asserted-by":"crossref","first-page":"14","DOI":"10.5152\/tjg.2018.17330","article-title":"Liver fibrosis","volume":"29","author":"Ayd\u0131n","year":"2018","journal-title":"Turk J Gastroenterol"},{"issue":"1","key":"10.1016\/j.jgr.2023.11.004_bib57","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.jgr.2023.11.004_bib58","doi-asserted-by":"crossref","DOI":"10.3390\/cells9010024","article-title":"Metabolic hallmarks of hepatic stellate cells in liver fibrosis","volume":"9","author":"Khomich","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.jgr.2023.11.004_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106657","article-title":"Astaxanthin: a promising therapeutic agent for organ fibrosis","volume":"188","author":"Li","year":"2023","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jgr.2023.11.004_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.671640","article-title":"Cellular mechanisms of liver fibrosis","volume":"12","author":"Acharya","year":"2021","journal-title":"Front Pharmacol"},{"issue":"11","key":"10.1016\/j.jgr.2023.11.004_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/cells8111419","article-title":"TGF-\u0392 in hepatic stellate cell activation and liver fibrogenesis-updated 2019","volume":"8","author":"Dewidar","year":"2019","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.jgr.2023.11.004_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/nu15030741","article-title":"Aerobic Exercise ameliorates myocardial fibrosis via affecting vitamin D receptor and transforming growth factor-beta1 signaling in vitamin D-deficient mice","volume":"15","author":"Cui","year":"2023","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.jgr.2023.11.004_bib63","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41419-020-2597-7","article-title":"Ginsenoside Rg3 promotes regression from hepatic fibrosis through reducing inflammation-mediated autophagy signaling pathway","volume":"11","author":"Liu","year":"2020","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.jgr.2023.11.004_bib64","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA: A Cancer J Clinicians"},{"key":"10.1016\/j.jgr.2023.11.004_bib65","article-title":"Cancer stem cells in hepatocellular carcinoma: an overview and promising therapeutic strategies","volume":"10","author":"Wang","year":"2018","journal-title":"Therapeut Adv Med Oncol"},{"key":"10.1016\/j.jgr.2023.11.004_bib66","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/7512159","article-title":"Aberrant metabolism in hepatocellular carcinoma provides diagnostic and therapeutic opportunities","volume":"2018","author":"De Matteis","year":"2018","journal-title":"Oxid Med Cell Longev"},{"issue":"5","key":"10.1016\/j.jgr.2023.11.004_bib67","first-page":"1295","article-title":"Antitumor effects of ginsenoside Rg3 on human hepatocellular carcinoma cells","volume":"5","author":"Zhang","year":"2012","journal-title":"Mol Med Rep"},{"issue":"8","key":"10.1016\/j.jgr.2023.11.004_bib68","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1016\/j.fct.2012.05.027","article-title":"Reactive oxygen species mediated ginsenoside Rg3- and Rh2-induced apoptosis in hepatoma cells through mitochondrial signaling pathways","volume":"50","author":"Park","year":"2012","journal-title":"Food Chem Toxicol"},{"issue":"31","key":"10.1016\/j.jgr.2023.11.004_bib69","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.3748\/wjg.v17.i31.3605","article-title":"Ginsenoside Rg3 inhibit hepatocellular carcinoma growth via intrinsic apoptotic pathway","volume":"17","author":"Jiang","year":"2011","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.jgr.2023.11.004_bib70","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1248\/bpb.b14-00603","article-title":"Stereoisomer-specific anticancer activities of ginsenoside Rg3 and Rh2 in HepG2 cells: disparity in cytotoxicity and autophagy-inducing effects due to 20(S)-epimers","volume":"38","author":"Cheong","year":"2015","journal-title":"Biol Pharm Bull"},{"issue":"7","key":"10.1016\/j.jgr.2023.11.004_bib71","doi-asserted-by":"crossref","first-page":"H1430","DOI":"10.1111\/1750-3841.12518","article-title":"Stereospecificity of ginsenoside Rg3 in the promotion of cellular immunity in hepatoma H22-bearing mice","volume":"79","author":"Wu","year":"2014","journal-title":"J Food Sci"},{"issue":"4","key":"10.1016\/j.jgr.2023.11.004_bib72","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.3892\/mmr.2017.6255","article-title":"Effects of R type and S type ginsenoside Rg3 on DNA methylation in human hepatocarcinoma cells","volume":"15","author":"Teng","year":"2017","journal-title":"Mol Med Rep"},{"issue":"8","key":"10.1016\/j.jgr.2023.11.004_bib73","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1142\/S0192415X18500969","article-title":"Ginsenoside Rg3 decreases NHE1 expression via inhibiting EGF-EGFR-ERK1\/2-HIF-1 alpha pathway in hepatocellular carcinoma: a novel antitumor mechanism","volume":"46","author":"Li","year":"2018","journal-title":"Am J Chin Med"},{"issue":"6","key":"10.1016\/j.jgr.2023.11.004_bib74","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1248\/bpb.b18-00852","article-title":"Ginsenoside Rg3 combined with oxaliplatin inhibits the proliferation and promotes apoptosis of hepatocellular carcinoma cells via downregulating PCNA and cyclin D1","volume":"42","author":"Shan","year":"2019","journal-title":"Biological Pharmaceut Bulletin"},{"issue":"4","key":"10.1016\/j.jgr.2023.11.004_bib75","first-page":"212","article-title":"Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths","volume":"61","author":"Siegel","year":"2011","journal-title":"CA: A Cancer J Clinicians"},{"issue":"5\u20136","key":"10.1016\/j.jgr.2023.11.004_bib76","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1002\/jcb.29591","article-title":"Emerging roles of HOTAIR in human cancer","volume":"121","author":"Yuan","year":"2020","journal-title":"J Cell Biochem"},{"issue":"1","key":"10.1016\/j.jgr.2023.11.004_bib77","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1080\/21655979.2021.1932211","article-title":"Ginsenoside-Rg3 inhibits the proliferation and invasion of hepatoma carcinoma cells via regulating long non-coding RNA HOX antisense intergenic","volume":"12","author":"Pu","year":"2021","journal-title":"Bioengineered"},{"issue":"9","key":"10.1016\/j.jgr.2023.11.004_bib78","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/s41419-018-0976-0","article-title":"ARHGAP9 suppresses the migration and invasion of hepatocellular carcinoma cells through up-regulating FOXJ2\/E-cadherin","volume":"9","author":"Zhang","year":"2018","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.jgr.2023.11.004_bib79","first-page":"965","article-title":"Ginsenoside Rg3 inhibits the migration and invasion of liver cancer cells by increasing the protein expression of ARHGAP9","volume":"17","author":"Sun","year":"2019","journal-title":"Oncol Lett"},{"key":"10.1016\/j.jgr.2023.11.004_bib80","article-title":"Ginsenoside Rg3 prolongs survival of the orthotopic hepatocellular carcinoma model by inducing apoptosis and inhibiting angiogenesis","volume":"2019","author":"Hu","year":"2019","journal-title":"Anal Cell Pathol (Amst)"},{"issue":"1","key":"10.1016\/j.jgr.2023.11.004_bib81","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1124\/jpet.110.175786","article-title":"Activation of phosphatidylinositol 3-kinase\/Akt signaling pathway mediates acquired resistance to sorafenib in hepatocellular carcinoma cells","volume":"337","author":"Chen","year":"2011","journal-title":"J Pharmacol Experiment Therapeut"},{"key":"10.1016\/j.jgr.2023.11.004_bib82","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2147\/JHC.S285726","article-title":"Elucidating the molecular basis of sorafenib resistance in HCC: current findings and future directions","volume":"8","author":"Fornari","year":"2021","journal-title":"J Hepatocell Carcinoma"},{"issue":"6","key":"10.1016\/j.jgr.2023.11.004_bib83","first-page":"3816","article-title":"Synergistic activity of magnolin combined with B-RAF inhibitor SB590885 in hepatocellular carcinoma cells via targeting PI3K-AKT\/mTOR and ERK MAPK pathway","volume":"11","author":"Wang","year":"2019","journal-title":"American J Translat Res"},{"key":"10.1016\/j.jgr.2023.11.004_bib84","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.biopha.2017.11.006","article-title":"Synergistic anticancer activity of 20(S)-Ginsenoside Rg3 and Sorafenib in hepatocellular carcinoma by modulating PTEN\/Akt signaling pathway","volume":"97","author":"Lu","year":"2018","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"10.1016\/j.jgr.2023.11.004_bib85","doi-asserted-by":"crossref","first-page":"13919","DOI":"10.1080\/21655979.2022.2074616","article-title":"Ginsenoside Rg3 and sorafenib combination therapy relieves the hepatocellular carcinomaprogression through regulating the HK2-mediated glycolysis and PI3K\/Akt signaling pathway","volume":"13","author":"Wei","year":"2022","journal-title":"Bioengineered"},{"issue":"3","key":"10.1016\/j.jgr.2023.11.004_bib86","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jgr.2021.07.002","article-title":"Ginsenoside Rg3 in combination with artesunate overcomes sorafenib resistance in hepatoma cell and mouse models","volume":"46","author":"Chen","year":"2022","journal-title":"J Ginseng Res"},{"issue":"3","key":"10.1016\/j.jgr.2023.11.004_bib87","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1158\/1535-7163.MCT-12-0054","article-title":"Sensitization of TRAIL-induced cell death by 20(S)-ginsenoside Rg3 via CHOP-mediated DR5 upregulation in human hepatocellular carcinoma cells","volume":"12","author":"Lee","year":"2013","journal-title":"Mol Cancer Ther"},{"issue":"12","key":"10.1016\/j.jgr.2023.11.004_bib88","doi-asserted-by":"crossref","first-page":"4438","DOI":"10.18632\/oncotarget.2034","article-title":"20(S)-Ginsenoside Rg3 is a novel inhibitor of autophagy and sensitizes hepatocellular carcinoma to doxorubicin","volume":"5","author":"Kim","year":"2014","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.jgr.2023.11.004_bib89","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00535-011-0511-x","article-title":"Early evaluation of transcatheter arterial chemoembolization-refractory hepatocellular carcinoma","volume":"47","author":"Yamanaka","year":"2012","journal-title":"J Gastroenterol"},{"issue":"6","key":"10.1016\/j.jgr.2023.11.004_bib90","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1001\/jamaoncol.2015.2189","article-title":"Transcatheter arterial chemoembolization plus radiotherapy compared with chemoembolization alone for hepatocellular carcinoma: a systematic review and meta-analysis","volume":"1","author":"Huo","year":"2015","journal-title":"JAMA Oncology"},{"issue":"3","key":"10.1016\/j.jgr.2023.11.004_bib91","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3892\/etm.2012.873","article-title":"Hepatic arterial administration of ginsenoside Rg3 and transcatheter arterial embolization for the treatment of VX2 liver carcinomas","volume":"5","author":"Yu","year":"2013","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.jgr.2023.11.004_bib92","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.2147\/OTT.S69830","article-title":"Ginsenoside Rg3 attenuates hepatoma VEGF overexpression after hepatic artery embolization in an orthotopic transplantation hepatocellular carcinoma rat model","volume":"7","author":"Zhou","year":"2014","journal-title":"OncoTargets and Therapy"},{"issue":"2","key":"10.1016\/j.jgr.2023.11.004_bib93","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1148\/radiol.2016150719","article-title":"Prospective study of transcatheter arterial chemoembolization (TACE) with ginsenoside Rg3 versus TACE alone for the treatment of patients with advanced hepatocellular carcinoma","volume":"280","author":"Zhou","year":"2016","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.jgr.2023.11.004_bib94","first-page":"711","article-title":"Liposomes co-loaded with ursolic acid and ginsenoside Rg3 in the treatment of hepatocellular carcinoma","volume":"68","author":"Wang","year":"2021","journal-title":"Acta Biochim Pol"},{"issue":"1","key":"10.1016\/j.jgr.2023.11.004_bib95","first-page":"109","article-title":"Hyaluronic acid-coated nanostructured lipid carriers for loading multiple traditional Chinese medicine components for liver cancer treatment","volume":"33","author":"Sun","year":"2020","journal-title":"Pakistan J Pharmaceut Sci"},{"key":"10.1016\/j.jgr.2023.11.004_bib96","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.omto.2021.08.008","article-title":"Multiple targeted self-emulsifying compound RGO reveals obvious anti-tumor potential in hepatocellular carcinoma","volume":"22","author":"He","year":"2021","journal-title":"Mol Ther Oncolytics"},{"issue":"2","key":"10.1016\/j.jgr.2023.11.004_bib97","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201905233","article-title":"Nanoparticle conjugation of ginsenoside Rg3 inhibits hepatocellular carcinoma development and metastasis","volume":"16","author":"Ren","year":"2020","journal-title":"Small"},{"issue":"2","key":"10.1016\/j.jgr.2023.11.004_bib98","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15020391","article-title":"Ginsenoside Rg3 reduces the toxicity of graphene oxide used for pH-responsive delivery of doxorubicin to liver and breast cancer cells","volume":"15","author":"Rahimi","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jgr.2023.11.004_bib99","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.1002\/jsfa.11763","article-title":"Micron and nano hybrid ufasomes from conjugated linoleic acid, their vesiculation and encapsulation of ginsenoside Rg3","volume":"102","author":"Liu","year":"2022","journal-title":"J Sci Food Agric"},{"key":"10.1016\/j.jgr.2023.11.004_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2021.130239","article-title":"Lactoferrin-ginsenoside Rg3 complex ingredients: study of interaction mechanism and preparation of oil-in-water emulsion","volume":"363","author":"Yan","year":"2021","journal-title":"Food Chem"}],"container-title":["Journal of Ginseng Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1226845323001513?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1226845323001513?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T13:37:22Z","timestamp":1778593042000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1226845323001513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":100,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1226845323001513"],"URL":"https:\/\/doi.org\/10.1016\/j.jgr.2023.11.004","relation":{},"ISSN":["1226-8453"],"issn-type":[{"value":"1226-8453","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The pharmacological role of Ginsenoside Rg3 in liver diseases: A review on molecular mechanisms","name":"articletitle","label":"Article Title"},{"value":"Journal of Ginseng Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgr.2023.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Korean Society of Ginseng. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}